High-stakes Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit
Go back to High-stakes Novo Nordisk Alzheimer's studies could yield answers on GLP-1 benefit| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.80 +1.68 (3.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.12 | 52 Week High | $59.00 | |||
| Open | $46.05 | 52 Week Low | $32.80 | |||
| Day High | $47.01 | P/E | N/A | |||
| Day Low | $45.91 | EPS | $0.00 | |||
| Volume | 7,797,116 | |||||
